Cited by 229Bone Metabolism and DiseasesNeuropeptides and Animal PhysiologyBone health and osteoporosis research

The DOI matches its Crossref record; 105 of the 106 references it cites were found in a registry or an index.

Regulation of bone remodeling by the central and peripheral nervous system

Open access

Elefteriou, Florent·2008·Archives of Biochemistry and Biophysics

DOI 10.1016/j.abb.2008.03.016PMC PMC2430105

Open this paper in CoChat — free account

Abstract

The homeostatic nature of bone remodeling has become a notion further supported lately by the demonstration that neuropeptides and their receptors regulate osteoblast and osteoclast function in vivo. Following initial studies reporting the presence of nerves and nerve-derived products within the bone microenvironment and the expression of receptors for these neuropeptides in bone cells, new experimental and mechanistic evidence based on in vivo murine genetic and pharmacologic models recently demonstrated that inputs from the central and peripheral nervous system feed into the already complex regulatory machinery controlling bone remodeling. The function of a number of "osteo-neuromediators" has been characterized, including norepinephrine and the beta2-adrenergic receptor, Neuropeptide Y and the Y1 and Y2 receptors, endocannabinoids and the CB1 and CB2 receptors, as well as dopamine, serotonin and their receptors and transporters, Calcitonin gene-related peptide, and neuronal NOS. This new body of evidence suggests that neurons in the central nervous system integrate clues from the internal and external milieux, such as energy homeostasis, glycemia or reproductive signals, with the regulation of bone remodeling. The next major tasks in this new area of bone biology will be to understand, at the molecular level, the mechanisms by which common central neural systems regulate and integrate these major physiological functions, the relative importance of the central and peripheral actions of neuropeptides present in both compartments and their relationship, and how bone cells signal back to central centers, because the definition of a homeostatic function implies the existence of feedback signals. Together, these findings shed a new light on the complexity of the mechanisms regulating bone remodeling and uncovered new potential therapeutic strategies for the design of bone anabolic treatments. This review summarizes the latest advances in this area, focusing on investigations based on in vivo animal studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.abb.2008.03.016

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Identification and expression cloning of a leptin receptor, OB-R.
Tartaglia, L. A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G. J., Campfield, L. A., Clark, F. T., Deeds, J., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90151-5 · Cited by 3,496
Endocrine regulation of energy metabolism by the skeleton
Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.047 · Cited by 2,554
Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
Amara, S. G., Jonas, V., Rosenfeld, M. G., Ong, E. S., & Evans, R. M. (1982) · Nature · doi:10.1038/298240a0 · Cited by 2,105
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Leptin Regulates Bone Formation via the Sympathetic Nervous System
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., & Karsenty, G. (2002) · Cell · doi:10.1016/s0092-8674(02)01049-8 · Cited by 1,735
Self-citation
Leptin
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Leptin regulation of bone resorption by the sympathetic nervous system and CART
Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., et al. (2005) · Nature · doi:10.1038/nature03398 · Cited by 1,311
Self-citation
Hypothalamic CART is a new anorectic peptide regulated by leptin
Kristensen, P. L., Judge, M. E., Thim, L., Ribel, U., Christjansen, K. N., Wulff, B. S., Clausen, J. T., Jensen, P. B., Madsen, O. D., Vrang, N., et al. (1998) · Nature · doi:10.1038/29993 · Cited by 1,282
ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology
Yang, X., Matsuda, K., Bialek, P., Jacquot, S., Masuoka, H. C., Schinke, T., Li, L., Brancorsini, S., Sassone‐Corsi, P., Townes, T. M., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00344-7 · Cited by 822
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T., & Matsuo, K. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.012 · Cited by 777
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
Panikashvili, D., Simeonidou, C., Ben‐Shabat, S., Hanuš, L., Breuer, A., Mechoulam, R., & Shohami, E. (2001) · Nature · doi:10.1038/35097089 · Cited by 752
The Molecular Clock Mediates Leptin-Regulated Bone Formation
Fu, L., Patel, M. S., Bradley, A., Wagner, E. F., & Karsenty, G. (2005) · Cell · doi:10.1016/j.cell.2005.06.028 · Cited by 590
Peripheral cannabinoid receptor, CB2, regulates bone mass
Ofek, O., Karsak, M., Leclerc, N., Fogel, M., Frenkel, B., Wright, K. L., Tam, J., Attar-Namdar, M., Kram, V., Shohami, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504187103 · Cited by 547
Bone Mineral Density in Women with Depression
Michelson, D., Stratakis, C., Hill, L., Reynolds, J., Galliven, E., Chrousos, G., & Gold, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351602 · Cited by 471
Hypothalamic Y2 receptors regulate bone formation
Baldock, P. A. J., Sainsbury, A., Couzens, M., Enriquez, R. F., Thomas, G. P., Gardiner, E. M., & Herzog, H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14588 · Cited by 434
Leptin deficiency produces contrasting phenotypes in bones of the limb and spine
Hamrick, M. W., Pennington, C., Newton, D. C., Xie, D., & Isales, C. M. (2003) · Bone · doi:10.1016/j.bone.2003.11.020 · Cited by 362
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
Idris, A. I., van 't Hof, R. J., Greig, I. R., Ridge, S. A., Baker, D., Ross, R. A., & Ralston, S. H. (2005) · Nature Medicine · doi:10.1038/nm1255 · Cited by 356
Type 5 Adenylyl Cyclase Disruption Increases Longevity and Protects Against Stress
Yan, L., Vatner, D. E., O’Connor, J. P., Ivessa, A., Ge, H., Chen, W., Hirotani, S., Ishikawa, Y., Sadoshima, J., & Vatner, S. F. (2007) · Cell · doi:10.1016/j.cell.2007.05.038 · Cited by 354
Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1receptors on peripheral sympathetic nerves
Ishac, E. J. N., Jiang, L., Lake, K. D., Varga, K., Abood, M. E., & Kunos, G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15639.x · Cited by 352
Use of β-Blockers and Risk of Fractures
Schlienger, R. G. (2004) · JAMA · doi:10.1001/jama.292.11.1326 · Cited by 342
Serum leptin level is a regulator of bone mass
Elefteriou, F., Takeda, S., Ebihara, K., Magré, J., Patano, N., Kim, C. A., Ogawa, Y., Liu, X., Ware, S. M., Craigen, W. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308744101 · Cited by 335
Self-citation
Activation of brown adipose tissue thermogenesis by the ventromedial hypothalamus
Perkins, M., Rothwell, N. J., Stock, M. J., & Stone, T. W. (1981) · Nature · doi:10.1038/289401a0 · Cited by 326
Glutamate signalling in non-neuronal tissues
Skerry, T. M., & Genever, P. G. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01642-4 · Cited by 309
Neuromedin U and Its Receptors: Structure, Function, and Physiological Roles
Brighton, P. J., Szekeres, P. G., & Willars, G. B. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.3 · Cited by 284
Osteocalcin in Human Serum: A Circadian Rhythm*
Gundberg, C. M., MARKOWITZ, M. E., Mizruchi, M. S., & Rosen, J. F. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-4-736 · Cited by 261
β-Adrenergic Blockers Reduce the Risk of Fracture Partly by Increasing Bone Mineral Density: Geelong Osteoporosis Study
Pasco, J. A., Henry, M. J., Sanders, K. M., Kotowicz, M. A., Seeman, E., & Nicholson, G. C. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301214 · Cited by 260
Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers
Serre, C., Farlay, D., Delmas, P. D., & Chenu, C. (1999) · Bone · doi:10.1016/s8756-3282(99)00215-x · Cited by 259
Heterotopic bone formation: clinical, laboratory, and imaging correlation.
Orzel, J. A., & Rudd, T. G. (1985) · PubMed · Cited by 245
Depression induces bone loss through stimulation of the sympathetic nervous system
Yirmiya, R., Goshen, I., Bajayo, A., Kreisel, T., Feldman, S., Tam, J., Trembovler, V., CSERNUS, V. J., Shohami, E., & Bab, I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604234103 · Cited by 234
Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues
Bjurholm, A., Andris Kreicbergs, A., Terenius, L. Y., Goldstein, M., & Schultzberg, M. (1988) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(88)90016-1 · Cited by 232
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case–control study
Rejnmark, L., Vestergaard, P., & Mosekilde, L. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000203845.26690.cb · Cited by 229
Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells
Huang, J., Guh, J., Chen, H., Hung, W., Lai, Y., & Chuang, L. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010401)81:1 · Cited by 226
Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion.
Satoh, N., Ogawa, Y., Katsuura, G., Numata, Y., Tsuji, T., Hayase, M., Ebihara, K., Masuzaki, H., Hosoda, K., Yoshimasa, Y., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1787 · Cited by 223
Inhibition of the Serotonin (5-Hydroxytryptamine) Transporter Reduces Bone Accrual during Growth
Warden, S. J., Robling, A. G., Sanders, M. S., Bliziotes, M. M., & Turner, C. H. (2004) · Endocrinology · doi:10.1210/en.2004-1259 · Cited by 223
Cannabinoid receptor type 2 gene is associated with human osteoporosis
Karsak, M., Cohen-Solal, M. E., Freudenberg, J., Ostertag, A., Morieux, C., Kornak, U., Essig, J., Erxlebe, E., Bab, I., Kubisch, C., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi370 · Cited by 222
Serotonin Regulates Osteoclast Differentiation Through Its Transporter
Battaglino, R. A., Fu, J., Späte, U., Ersoy, U., Joe, M., Sedaghat, L., & Stashenko, P. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040606 · Cited by 219
Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake
Bliziotes, M. M., Eshleman, A. J., Zhang, X.-W., & Wiren, K. M. (2001) · Bone · doi:10.1016/s8756-3282(01)00593-2 · Cited by 215
Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway
Hanada, R., Teranishi, H., Pearson, J. T., Kurokawa, M., Hosoda, H., Fukushima, N., Fukue, Y., Serino, R., Fujihara, H., Ueta, Y., et al. (2004) · Nature Medicine · doi:10.1038/nm1106 · Cited by 208
Central control of bone remodeling by neuromedin U
Sato, S., Hanada, R., Kimura, A., Abe, T., Μatsumoto, T., Iwasaki, M., Inose, H., Ida, T., Mieda, M., Takeuchi, Y., et al. (2007) · Nature Medicine · doi:10.1038/nm1640 · Cited by 208
Expression of Serotonin Receptors in Bone
Westbroek, I., van der Plas, A., de Rooij, K. E., Klein‐Nulend, J., & Nijweide, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101824200 · Cited by 206
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling
Tam, J., Trembovler, V., Marzo, V. D., Petrosino, S., Leo, G., Alexandrovich, A., Regev, E., Casap, N., Shteyer, A., Ledent, C. A., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7957com · Cited by 203
Decreased Bone Formation and Osteopenia in Mice Lacking α-Calcitonin Gene-Related Peptide
Schinke, T., Liese, S., Priemel, M., Haberland, M., Schilling, A. F., Catala-Lehnen, P., Blicharski, D., Rueger, J. M., Gagel, R. F., Emeson, R. B., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040915 · Cited by 177
Effects of antihypertensive drug treatments on fracture outcomes: a meta‐analysis of observational studies
Wiens, M. O., Etminan, M., Gill, S. S., & Takkouche, B. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01695.x · Cited by 173
Depression: a major, unrecognized risk factor for osteoporosis?
Cizza, G., Ravn, P., Chrousos, G. P., & Gold, P. W. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00407-6 · Cited by 170
Low lumbar bone mineral density in patients with major depression
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.11.1691 · Cited by 165
Calcitonin gene-related peptide inhibits osteoclastic bone resorption: A comparative study
Zaidi, M., Fuller, K., Bevis, P. J. R., Gaines-Das, R. E., Chambers, T. J., & MacIntyre, I. M. (1987) · Calcified Tissue International · doi:10.1007/bf02555699 · Cited by 164
Involvement of Neuronal Cannabinoid Receptor CB1 in Regulation of Bone Mass and Bone Remodeling
Tam, J., Ofek, O., Fride, E., Ledent, C. A., Gabet, Y., Müller, R., Zimmer, A. D., Mackie, K., Mechoulam, R., Shohami, E., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026435 · Cited by 163
β-Blocker Use, BMD, and Fractures in the Study of Osteoporotic Fractures
Reid, I. R., Gamble, G. D., Grey, A. B., Black, D. M., Ensrud, K. E., Browner, W. S., & Bauer, D. C. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041202 · Cited by 156
Central autonomic control of the bone marrow: Multisynaptic tract tracing by recombinant pseudorabies virus
Dénes, Á., Boldogkoi, Z., Uhereczky, G., Hornyák, Á., Rusvai, M., Palkovits, M., & Kovács, K. J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.060 · Cited by 155
Expression of Nitric Oxide Synthase Isoforms in Bone and Bone Cell Cultures
Helfrich, M., Evans, D. M., Grabowski, P., Pollock, J. S., Ohshima, H., & Ralston, S. H. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.7.1108 · Cited by 155
Elevated Sympathetic Nervous Activity in Mice Deficient in αCGRP
Oh-hashi, Y., Shindo, T., Kurihara, Y., Imai, T., Wang, Y., Morita, H., Imai, Y., Kayaba, Y., Nishimatsu, H., Suematsu, Y., et al. (2001) · Circulation Research · doi:10.1161/hh2301.100812 · Cited by 152
TCR affinity and negative regulation limit autoimmunity
Gronski, M. A., Boulter, J. M., Moskophidis, D., Nguyen, L. T., Holmberg, K., Elford, A. R., Deenick, E. K., Kim, H. O., Penninger, J. M., Odermatt, B., et al. (2004) · Nature Medicine · doi:10.1038/nm1114 · Cited by 151
Neuronal regulation of bone metabolism and anabolism: Calcitonin gene‐related peptide‐, substance P‐, and tyrosine hydroxylase‐containing nerves and the bone
Imai, S., & Matsusue, Y. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10119 · Cited by 151
Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106–01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells
Bjurholm, A., Kreicbergs, A., Schultzberg, M., & Dr. Lerner, U. H. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070903 · Cited by 145
Greater Bone Formation of Y2 Knockout Mice Is Associated with Increased Osteoprogenitor Numbers and Altered Y1 Receptor Expression
Lundberg, P., Allison, S. J., Lee, N. J., Baldock, P. A. J., Brouard, N., Rost, S., Enriquez, R. F., Sainsbury, A., Lamghari, M., Simmons, P. J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609629200 · Cited by 143
Protective effect of β blockers in postmenopausal women: Influence on fractures, bone density, micro and macroarchitecture
Bonnet, N., Gadois, C., McCloskey, E. V., Lemineur, G., Lespessailles, É., Courteix, D., & Benhamou, C. L. (2007) · Bone · doi:10.1016/j.bone.2007.01.006 · Cited by 143
Neuroendocrine peptides in bone
Bjurholm, A. (1991) · International Orthopaedics · doi:10.1007/bf00186871 · Cited by 141
Targeted Expression of Calcitonin Gene-Related Peptide to Osteoblasts Increases Bone Density in Mice
Ballica, R., Valentijn, K., Khachatryan, A., Guerder, S., Kapadia, S., Gundberg, C., Gilligan, J., Flavell, R. A., & Vignery, A. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1067 · Cited by 133
Neuronal signaling and the regulation of bone remodeling
Elefteriou, F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5175-3 · Cited by 131
Self-citation
Evidence for a bone-kidney axis regulating phosphate homeostasis
Quarles, L. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319687 · Cited by 122
Comparison of the Effects of Calcitonin Gene-Related Peptide and Amylin on Osteoblasts
Dr. Cornish, J., Callon, K. E., Lin, C. Q., Xiao, C. L., Gamble, G. D., Cooper, G. J. S., & Reid, I. R. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.8.1302 · Cited by 121
Enhanced bone formation in lipodystrophic PPARγhyp/hyp mice relocates haematopoiesis to the spleen
Cock, T., Back, J., Elefteriou, F., Karsenty, G., Kastner, P., Chan, S. H., & Auwerx, J. H. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400254 · Cited by 121
Self-citation
The serotonin 5‐HT 2B receptor controls bone mass via osteoblast recruitment and proliferation
Collet, C., Schiltz, C., Geoffroy, V., Maroteaux, L., Launay, J., & de Vernejoul, M. C. (2007) · The FASEB Journal · doi:10.1096/fj.07-9209com · Cited by 119
Immunohistochemical and ultrastructural localization of CGRP-positive nerve fibers at the epiphyseal trabecules facing the growth plate of rat femurs
Hara‐Irie, F., Amizuka, N., & Ozawa, H. (1996) · Bone · doi:10.1016/8756-3282(95)00425-4 · Cited by 114
Effects of a β-Blocker on Bone Turnover in Normal Postmenopausal Women: A Randomized Controlled Trial
Reid, I. R., Lucas, J., Wattie, D. J., Horne, A. M., Bolland, M. J., Gamble, G. D., Davidson, J. S., & Grey, A. B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0573 · Cited by 112
Effects of β-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells
Arai, M., Nagasawa, T., Koshihara, Y., Yamamoto, S., & Togari, A. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(03)00042-9 · Cited by 110
Evaluation of the in Vivo and in Vitro Calcium Regulating Actions of Noncalcitonin Peptides Produced via Calcitonin Gene Expression*
ROOS, B. A., FISCHER, J. A., PIGNAT, W., ALANDER, C. B., & RAISZ, L. G. (1986) · Endocrinology · doi:10.1210/endo-118-1-46 · Cited by 109
Synergistic Effects of Y2 and Y4 Receptors on Adiposity and Bone Mass Revealed in Double Knockout Mice
Sainsbury, A., Baldock, P. A. J., Schwarzer, C., Ueno, N., Enriquez, R. F., Couzens, M., Inui, A., Herzog, H., & Gardiner, E. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5225-5233.2003 · Cited by 109
Fracture Risk in Perimenopausal Women Treated with Beta-Blockers
Rejnmark, L., Vestergaard, P., Kassem, M. S., Rud, B., Kolthoff, N., Brixen, K., & Mosekilde, L. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0222-x · Cited by 108
Regulation of Bone Mass and Bone Turnover by Neuronal Nitric Oxide Synthase
Hof, R. V., MacPhee, J., Libouban, H., Helfrich, M., & Ralston, S. H. (2004) · Endocrinology · doi:10.1210/en.2004-0205 · Cited by 104
Functional characterization of N-methyl-d-aspartic acid-gated channels in bone cells
LAKETIć‐LJUBOJEVIć, I., Suva, L. J., Maathuis, F. J. M., Sanders, D., & Skerry, T. M. (1999) · Bone · doi:10.1016/s8756-3282(99)00224-0 · Cited by 104
The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts
Vignery, A., & McCarthy, T. L. (1996) · Bone · doi:10.1016/8756-3282(96)00017-8 · Cited by 101
The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression
Niederhoffer, N., Schmid, K., & Szabó, B. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0755-y · Cited by 100
The osteogenic stimulating effect of neuroactive calcitonin gene-related peptide
Bernard, G. W., & Shih, C. (1990) · Peptides · doi:10.1016/0196-9781(90)90171-z · Cited by 97
Human Synthetic Calcitonin Gene-Related Peptide Inhibits Bone Resorptionin Vitro*
D'Souza, S. M., MacIntyre, I. M., Girgis, S. I., & Mundy, G. R. (1986) · Endocrinology · doi:10.1210/endo-119-1-58 · Cited by 95
Expression of Semaphorin‐3A and its receptors in endochondral ossification: Potential role in skeletal development and innervation
Gomez, C. G., Burt‐Pichat, B., Mallein‐Gérin, F., Merle, B., Delmas, P. D., Skerry, T. M., Vico, L., Malaval, L., & Chenu, C. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20512 · Cited by 94
Cart Overexpression Is the Only Identifiable Cause of High Bone Mass in Melanocortin 4 Receptor Deficiency
Ahn, J. D., Dubern, B., Lubrano-Berthelier, C., Clément, K., & Karsenty, G. (2006) · Endocrinology · doi:10.1210/en.2006-0281 · Cited by 90
Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats
Valentijn, K., Gutow, A. P., Troiano, N., Gundberg, C., Gilligan, J. P., & Vignery, A. (1997) · Bone · doi:10.1016/s8756-3282(97)00142-7 · Cited by 89
Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men
Yamada, Y., Ando, F., & Shimokata, H. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.5.791 · Cited by 89
Leptin Inhibits Bone Formation Not Only in Rodents, but Also in Sheep
Pogoda, P., Egermann, M., Schnell, J. C., Priemel, M., Schilling, A. F., Alini, M., Schinke, T., Rueger, J. M., Schneider, E. H., Clarke, I. J., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060709 · Cited by 88
Calcitonin gene‐related peptide, substance P, and tyrosine hydroxylase‐immunoreactive innervation of rat bone marrows: An immunohistochemical and ultrastructural investigation on possible efferent and afferent mechanisms
Imai, S., Tokunaga, Y., Maeda, T., Kikkawa, M., & Hukuda, S. (1997) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100150120 · Cited by 86
BETA‐BLOCKER USE, BONE MINERAL DENSITY, AND FRACTURE RISK IN OLDER WOMEN: RESULTS FROM THE EPIDEMIOLOGIE DE L'OSTÉOPOROSE PROSPECTIVE STUDY
Levasseur, R., Dargent‐Molina, P., Sabatier, J., Marcelli, C., & Bréart, G. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53178_7.x · Cited by 85
Bone histomorphometric and biomechanical abnormalities in mice homozygous for deletion of the dopamine transporter gene
Bliziotes, M. M., McLoughlin, S. W., Gunness, M. E., Fumagalli, F., Jones, S. R., & Caron, M. G. (2000) · Bone · doi:10.1016/s8756-3282(99)00232-x · Cited by 81
Effects of calcitonin gene-related peptide on cyclic AMP formation in chicken, rat, and mouse bone cells
Michelangeli, V. P., Fletcher, A. E., Allan, E. H., Nicholson, G. C., & Martin, T. J. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040220 · Cited by 75
NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis
Merle, B., Itzstein, C., Delmas, P. D., & Chenu, C. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10625 · Cited by 75
Diurnal periodicity in the metabolic activity of bone tissue
Simmons, D., & Nichols, G. (1966) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1966.210.2.411 · Cited by 69
Anti-apoptotic action of nerve growth factor in mouse osteoblastic cell line
Mogi, M., Kondo, A., Kinpara, K., & Togari, A. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00705-0 · Cited by 68
Fluoxetine treatment increases trabecular bone formation in mice
Battaglino, R. A., Vokes, M. S., Schulze‐Späte, U., Sharma, A., Graves, D. T., Kohler, T., Müller, R., Yoganathan, S., & Stashenko, P. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21131 · Cited by 68
Long‐term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats
Gustafsson, B. I., Westbroek, I., Waarsing, J. H., Waldum, H. L., Solligård, E., Brunsvik, A., Dimmen, S., van Leeuwen, J. P. T. M., Weinans, H., & Syversen, U. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20733 · Cited by 67
Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders?☆
Akopian, A., Demulder, A., Ouriaghli, F. E., Corazza, F., Fondu, P., & Bergmann, P. (2000) · Peptides · doi:10.1016/s0196-9781(00)00185-6 · Cited by 64
β-blockers Increase Bone Mineral Density
Türker, S., Karatosun, V., & Günal, İ. (2006) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000200242.52802.6d · Cited by 63
β-blocker use and risk of fractures in men and women from the general population: the MONICA/KORA Augsburg cohort study
Meisinger, C., Heier, M., Lang, O., & Döring, A. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0354-8 · Cited by 59
Post-traumatic hormonal disturbances: Prolactin as a link between head injury and enhanced osteogenesis
Wildburger, R., Žarković, N., Tonkovic, G., Škorić, T., Frech, S., Hartleb, M., Lončarić, I., & Žarković, K. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350319 · Cited by 55
Alteration of Trabecular Bone under Chronic β2 Agonists Treatment
Bonnet, N., Brunet-Imbault, B., Arlettaz, A., Horcajada, M. N., Collomp, K., Benhamou, C. L., & Courteix, D. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000177592.82507.95 · Cited by 53
Calcitonin Gene Related Peptide Enhances Bone Colony Development In Vitro
Shih, C., & Bernard, G. W. (1997) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199701000-00043 · Cited by 49
Expression of the CT/CGRP Gene and Its Regulation by Dibutyryl Cyclic Adenosine Monophosphate in Human Osteoblastic Cells
Drissi, H., Hott, M., Marie, P. J., & Lasmoles, F. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1805 · Cited by 43
Immunohistochemical and ultrastructural localization of CGRP-positive nerve fibers at the epiphyseal trabecules facing the growth plate of rat femurs
入江史子, & 原, 史. (1995) · Medical Entomology and Zoology · doi:10.11501/3104815 · Cited by 41
Human pulp cells respond to calcitonin gene-related peptide in vitro
Calland, J. W., Harris, S. E., & Carnes, D. L. (1997) · Journal of Endodontics · doi:10.1016/s0099-2399(97)80306-8 · Cited by 40
Osteoblastic glutamate receptor function regulates bone formation and resorption.
Af, T. (2002) · PubMed · Cited by 38
Leptin deficiency—Lessons in regional differences in the regulation of bone mass
Reid, I. R. (2003) · Bone · doi:10.1016/j.bone.2003.11.007 · Cited by 35
Calcitonin Gene-Related Peptide Stimulates Potassium Efflux through Adenosine Triphosphate-Sensitive Potassium Channels and Produces Membrane Hyperpolarization in Osteoblastic UMR106 Cells
Kawase, T., & Burns, D. M. (1998) · Endocrinology · doi:10.1210/endo.139.8.6151 · Cited by 27
Different skeletal regional response to continuous brain infusion of leptin in the rat
GUIDOBONO, F., Pagani, F., Sibilia, V., Netti, C., Lattuada, N., Rapetti, D., Mrak, E., Villa, I., Cavani, F., Bertoni, L., et al. (2005) · Peptides · doi:10.1016/j.peptides.2005.10.014 · Cited by 26
Glutamatergic regulation of bone remodeling.
Chenu, C. (2002) · PubMed · Cited by 21
An X-ray absorptiometry study of reflex sympathetic dystrophy syndrome.
Laroche, M., Redon-Dumolard, A., Mazières, B., & Bernard, J.-C. (1997) · PubMed · Cited by 10

Flagged first, then by citations

1 of the 106 references couldn’t be matched to a known paper.

Research works printed but not linked: 7

Baldock, 2002, J. Clin. Invest., 109, 915, 10.1172/JCI0214588 · DOI
Orzel, 1985, J. Nucl. Med., 26, 125
Yamada, 2007, Int. J. Mol. Med., 19, 791
Laroche, 1997, Rev. Rhum. Engl. Ed., 64, 106
Chenu, 2002, J. Musculoskelet. Neuronal Interact., 2, 282
Taylor, 2002, J. Musculoskelet. Neuronal Interact., 2, 285
Shih, 1997, Clin. Orthop. Relat. Res., 335

Sorted by citations

Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
Florencio-Silva, R., Sasso, G. R. D. S., Sasso-Cerri, E., Simões, M. J., & Cerri, P. S. (2015) · BioMed Research International · doi:10.1155/2015/421746 · Cited by 2,044
Osteoprotection by semaphorin 3A
Hayashi, M., Nakashima, T., Taniguchi, M., Kodama, T., Kumanogoh, A., & Takayanagi, H. (2012) · Nature · doi:10.1038/nature11000 · Cited by 606
Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption
Sims, N. A., & Gooi, J. H. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.016 · Cited by 513
Osteoimmunology: The conceptual framework unifying the immune and skeletal systems
Okamoto, K., Nakashima, T., Shinohara, M., Negishi-Koga, T., Komatsu, N., Terashima, A., Sawa, S., Nitta, T., & Takayanagi, H. (2017) · Physiological Reviews · doi:10.1152/physrev.00036.2016 · Cited by 534
Osteoblast physiology in normal and pathological conditions
Neve, A., Corrado, A., & Cantatore, F. P. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1086-1 · Cited by 354

See all 229

Authors: Elefteriou, F.
Affiliations: Vanderbilt University (US)
Corresponding author: Elefteriou, Florent
ORCID: Elefteriou, Florent
Venue: Archives of Biochemistry and Biophysics
Publisher: Elsevier BV
Published: 2008-05
Volume: 473
Issue: 2
Pages: 231-236
ISSN: 0003-9861 (ISSN-L)
DOI: 10.1016/j.abb.2008.03.016
PMC: PMC2430105
OpenAlex: W1963686806
Cited by: 229
References: 106
Citations by year: 2026: 9 · 2025: 8 · 2024: 9 · 2023: 11 · 2022: 8 · 2021: 9 · 2020: 17 · 2019: 14 · 2018: 9 · 2017: 12 · 2016: 5 · 2015: 13 · 2014: 27 · 2013: 17 · 2012: 16
FWCI: 1.16
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Archives of Biochemistry and Biophysics (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Vanderbilt University
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058883, R21DK074994)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords: bone remodeling, bone homeostasis, neuropeptides, norepinephrine, beta2-adrenergic receptor, neuropeptide Y, Y1 receptor, Y2 receptor, endocannabinoids, CB1 receptor, CB2 receptor, dopamine, serotonin, calcitonin gene-related peptide, neuronal nitric oxide synthase, osteoblasts, osteoclasts, central nervous system, peripheral nervous system, bone microenvironment, energy homeostasis, bone anabolic therapy
MeSH terms: Animals, Brain, Calcitonin, Humans, Hypothalamus, Neurons, Neuropeptide Y, Osteoblasts, Bone Remodeling, Receptors, Neuropeptide Y, Peripheral Nervous System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regulation of bone remodeling by the central and peripheral nervous system

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks